Residents

CURx Pharmaceuticals

CURx Pharmaceuticals

We develop therapeutics that we are confident will provide effective solutions to currently unmet needs of patients with chronic diseases. Our strategy is to search for and license mid- to late-stage molecules that fulfill our criteria for further development. These criteria include sound scientific rationale, strong preclinical and clinical study results, defined regulatory pathway to approval and robust IP protection.

Area of focus: 
Infectious Diseases & Vaccines
Commencement date: 
09/02/2013

Share